startup

GNA Biosolutions

Developing instruments, OEM modules and tests for the ultrafast, molecular biological detection of a wide range of pathogens. The core is a specially developed technology called laser PCR.
  • Chemicals/Pharmaceuticals
  • Growth Stage
  • Manufacturing
  • B2B
  • 2010
  • 11-50 Employees
  • Found
  • Martinsried, DE
  • gna-bio.com
  • GNA Biosolutions GmbH
  • Bayern

Profile is not claimed et

This profile is created by the Startbase Analyst Team. If you are a team member of this company you can claim the profile in order to make changes to it.

Is this your company? Claim profile

About the Team

Are you part of this team?

Management

Federico Bürsgens Geschäftsführer
since 2010
Lars Ullerich Geschäftsführer
since 2010
Joachim Stehr Geschäftsführer
since 2010

Alumni

2016 - 2018
2 years, 1 months 		Frank Krieg-Schneider
Geschäftsführer

News about GNA Biosolutions

Recent mentions of GNA Biosolutions in podcasts & videos:

Jobs at GNA Biosolutions:

Related companies

Robert Bosch Venture Capital
Investor 2007 Gerlingen
Robert Bosch Venture Capital
RBVC invests in seed, early-, and late-stage Venture Capital rounds and participates in the follow-on investments in privately held companies.
TeamViewer
Startup 2009 Göppingen
TeamViewer
Global platform for digital networking of people and machines to establish solutions such as remote access, remote maintenance.
HelloFresh
Startup 2015 Berlin
HelloFresh
Distribution of cooking boxes with recipes and fresh ingredients for individual dishes.

Other Startups nearby

Dust BioSolutions
Startup 2011 Martinsried
Dust BioSolutions
Dust BioSolutions is a start-up company focusing on industrial applications of biotechnology.
Eisbach
Startup 2019 Planegg-Martinsried
Eisbach
Development of drugs targeting chromatin regulatory mechanisms important for tumors.
ChromoTek
Startup 2008 Martinsried
ChromoTek
Development and commercialization of Nanobody-based reagents.
Lindis Biotech
Startup 2010 Planegg
Lindis Biotech
Development of Triomab® antibodies - a new class of T-cell activating bispecific antibodies that enable the immune system to transform malignant cancers into treatable and potentially curable diseases.
Bind-X
Startup 2013 Planegg
Bind-X
Industrial applications in the field of biotechnology.

FYI: English edition available

Hello my friend, have you been stranded on the German edition of Startbase? At least your browser tells us, that you do not speak German - so maybe you would like to switch to the English edition instead?

Go to English edition

FYI: Deutsche Edition verfügbar

Hallo mein Freund, du befindest dich auf der Englischen Edition der Startbase und laut deinem Browser sprichst du eigentlich auch Deutsch. Magst du die Sprache wechseln?

Deutsche Edition öffnen